EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,446 | -18.9% | 408,758 | 0.0% | 0.02% | -16.7% |
| Q2 2023 | $7,946 | +14.9% | 408,758 | +67.7% | 0.02% | +12.5% |
| Q1 2023 | $6,915 | +56.2% | 243,736 | +61.0% | 0.02% | +60.0% |
| Q4 2022 | $4,426 | -97.1% | 151,418 | +4503.8% | 0.01% | – |
| Q4 2020 | $153,000 | -73.9% | 3,289 | -76.2% | 0.00% | -100.0% |
| Q3 2020 | $586,000 | -92.8% | 13,800 | -91.8% | 0.00% | -94.1% |
| Q2 2020 | $8,084,000 | -45.1% | 168,501 | -47.4% | 0.02% | -52.8% |
| Q1 2020 | $14,730,000 | -33.6% | 320,227 | -13.3% | 0.04% | +2.9% |
| Q4 2019 | $22,180,000 | -15.1% | 369,177 | -20.0% | 0.04% | -18.6% |
| Q3 2019 | $26,110,000 | +16.0% | 461,558 | +14.1% | 0.04% | +19.4% |
| Q2 2019 | $22,515,000 | +78.4% | 404,369 | +61.7% | 0.04% | +80.0% |
| Q1 2019 | $12,622,000 | +276.2% | 250,004 | +200.2% | 0.02% | +233.3% |
| Q4 2018 | $3,355,000 | -45.8% | 83,289 | -6.8% | 0.01% | -33.3% |
| Q3 2018 | $6,194,000 | -86.2% | 89,341 | -84.9% | 0.01% | -87.1% |
| Q2 2018 | $44,839,000 | -0.9% | 592,642 | -31.0% | 0.07% | -2.8% |
| Q1 2018 | $45,268,000 | +15.5% | 859,142 | +17.1% | 0.07% | +16.1% |
| Q4 2017 | $39,200,000 | +188.6% | 733,822 | +222.1% | 0.06% | +181.8% |
| Q3 2017 | $13,585,000 | – | 227,794 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |